Stock listing
A2ANGZ Stock Price, News, Filings & Events — Gensight Biologics Sa
Selected listing: A2ANGZ · LS · EUR · DE
This page tracks Gensight Biologics Sa's A2ANGZ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2ANGZ:LS. A2ANGZ:LS is the stock-level entry point for investors researching Gensight Biologics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2ANGZ:LS
- Asset type
- Stock
- Market cap
- $35.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Gensight Biologics Sa A2ANGZ:LS stock context
This page tracks Gensight Biologics Sa's A2ANGZ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2ANGZ:LS. A2ANGZ:LS is the stock-level entry point for investors researching Gensight Biologics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Gensight Biologics Sa
GenSight Biologics S A : Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
September 29, 2026
GenSight Biologics Provides September 2026 Business Updates
September 8, 2026
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
July 8, 2026
GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026
May 20, 2026
GenSight Biologics to Hold its Combined General Meeting on May 19, 2026
May 18, 2026
Research Gensight Biologics Sa
Gensight Biologics Sa investor report
Review AI stock analysis and investor report context for A2ANGZ:LS.
Gensight Biologics Sa company profile
View the public company page for Gensight Biologics Sa on 6ix.
Gensight Biologics Sa news
Read company news and market updates connected to Gensight Biologics Sa.
Gensight Biologics Sa investor events
Find investor webinars, events, and replay context for Gensight Biologics Sa.
Alternate listings
SIGHT:EURONEXT
FR · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
0RIM:LSE
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:GETTEX
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
A2ANGZ:LSX
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
SIGHTP:AQUISEU
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
GSGTF:OTC
US · USD
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
SIGHTP:AQUISUK
GB · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:DUS
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:FWB
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:HAM
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:MUN
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.
G49N:SWB
DE · EUR
Alternate listing for Gensight Biologics Sa; the primary context on this page is A2ANGZ:LS.